FRANKINCENSE

FRANKINCENSE was reported 61 times

FRANKINCENSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACQUIRED PROTEIN S DEFICIENCY 1 0.0909
1 CANNABIS INTERACTION 1 0.0769
2 MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL 3 0.0246
3 VIBRATION SYNDROME 1 0.0217
4 TYPE 3 DIABETES MELLITUS 1 0.0147
5 FAT REDISTRIBUTION 1 0.0043
6 SARS-COV-2 ANTIBODY TEST NEGATIVE 2 0.0042
7 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 1 0.0037
8 BONE CONTUSION 3 0.0033
9 CYSTITIS NONINFECTIVE 4 0.0030
10 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
11 NONINFECTIVE GINGIVITIS 4 0.0028
12 ENDOMETRIAL HYPERPLASIA 2 0.0025
13 DIPLEGIA 3 0.0015
14 DIARRHOEA INFECTIOUS 1 0.0013
15 DYSBIOSIS 1 0.0012
16 VACCINATION FAILURE 2 0.0012
17 PREMATURE MENOPAUSE 1 0.0011
18 ESSENTIAL TREMOR 1 0.0009
19 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
20 COLON OPERATION 1 0.0008
21 ESCHERICHIA TEST POSITIVE 1 0.0008
22 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
23 PANCREATIC ENZYMES INCREASED 1 0.0007
24 SKIN ABRASION 3 0.0006
25 OPHTHALMOPLEGIA 1 0.0006
26 GASTRIC DILATATION 1 0.0006
27 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
28 RED BLOOD CELL COUNT INCREASED 1 0.0004
29 PULMONARY PAIN 1 0.0003
30 IMMUNOSUPPRESSION 3 0.0003
31 CORONAVIRUS INFECTION 2 0.0003
32 APPENDICECTOMY 1 0.0003
33 BONE LESION 1 0.0003
34 CERVIX CARCINOMA 1 0.0003
35 INTRACRANIAL ANEURYSM 1 0.0002
36 TRIGEMINAL NEURALGIA 1 0.0002
37 GINGIVAL SWELLING 1 0.0002
38 LOCALISED OEDEMA 1 0.0002
39 GASTRITIS EROSIVE 1 0.0002
40 LIGAMENT SPRAIN 2 0.0002
41 PARTIAL SEIZURES 1 0.0002
42 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
43 MALNUTRITION 2 0.0002
44 HYPERTRIGLYCERIDAEMIA 1 0.0002
45 PLATELET COUNT ABNORMAL 1 0.0002
46 ADRENAL INSUFFICIENCY 2 0.0002
47 SECRETION DISCHARGE 2 0.0002
48 TENDON DISORDER 1 0.0002
49 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
50 LYMPHOEDEMA 1 0.0001
51 FORMICATION 1 0.0001
52 VISUAL FIELD DEFECT 1 0.0001
53 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
54 AFFECTIVE DISORDER 1 0.0001
55 SECOND PRIMARY MALIGNANCY 1 0.0001
56 BLOOD MAGNESIUM DECREASED 1 0.0001
57 COLD SWEAT 2 0.0001
58 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
59 CARDIOTOXICITY 1 0.0001
60 ANAL INCONTINENCE 1 0.0001
61 TOOTHACHE 2 0.0001
62 HYPERCHOLESTEROLAEMIA 1 0.0001
63 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
64 VITREOUS FLOATERS 1 0.0001
65 BODY TEMPERATURE DECREASED 1 0.0001
66 BLADDER DISORDER 1 0.0001
67 FEEDING DISORDER 2 0.0001
68 BODY TEMPERATURE INCREASED 2 0.0001
69 INITIAL INSOMNIA 1 0.0001
70 EYE DISCHARGE 1 0.0001
71 WEIGHT FLUCTUATION 1 0.0001
72 SCRATCH 1 0.0001
73 TOOTH FRACTURE 1 0.0001
74 CHOLECYSTECTOMY 1 0.0001
75 INFLUENZA LIKE ILLNESS 7 0.0001
76 MUSCLE SPASTICITY 1 0.0001
77 TOOTH EXTRACTION 1 0.0001
78 BRAIN OEDEMA 1 0.0001
79 NODULE 1 0.0001
80 BEDRIDDEN 1 0.0001
81 QUALITY OF LIFE DECREASED 1 0.0001
82 PERIPHERAL COLDNESS 1 0.0001
83 BRONCHOSPASM 1 0.0001
84 PARALYSIS 1 0.0001
85 IMPAIRED QUALITY OF LIFE 1 0.0001
86 URINARY INCONTINENCE 2 0.0001
87 RESPIRATORY DISORDER 2 0.0001
88 PRODUCT USE COMPLAINT 1 0.0001
89 COVID-19 11 0.0001
90 MUSCLE TIGHTNESS 1 0.0001
91 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
92 ECZEMA 3 0.0001
93 MUSCULOSKELETAL STIFFNESS 5 0.0001
94 BURNING SENSATION 4 0.0001
95 HEAD DISCOMFORT 1 0.0001
96 GASTROENTERITIS VIRAL 1 0.0001
97 C-REACTIVE PROTEIN INCREASED 2 0.0001
98 CONJUNCTIVITIS 1 0.0001
99 BLISTER 3 0.0001
100 COLITIS 2 0.0001
101 BLOOD URINE PRESENT 1 0.0001
102 INCREASED APPETITE 1 0.0001
103 CHILLS 6 0.0001
104 PSORIATIC ARTHROPATHY 2 0.0000
105 TOOTH LOSS 1 0.0000
106 DERMATITIS 1 0.0000
107 KNEE ARTHROPLASTY 1 0.0000
108 IMPAIRED WORK ABILITY 1 0.0000
109 LIVER FUNCTION TEST INCREASED 1 0.0000
110 POOR QUALITY SLEEP 1 0.0000
111 AMNESIA 3 0.0000
112 TOOTH DISORDER 1 0.0000
113 GLOSSODYNIA 1 0.0000
114 MUSCULAR WEAKNESS 5 0.0000
115 MUSCLE TWITCHING 1 0.0000
116 CHEST PAIN 8 0.0000
117 BLOOD CHOLESTEROL INCREASED 2 0.0000
118 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
119 PRODUCT PRESCRIBING ERROR 1 0.0000
120 BLOOD PRESSURE FLUCTUATION 1 0.0000
121 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
122 LUNG DISORDER 2 0.0000
123 CELLULITIS 2 0.0000
124 PERIPHERAL SWELLING 6 0.0000
125 DIPLOPIA 1 0.0000
126 ARTHRITIS 3 0.0000
127 JOINT STIFFNESS 1 0.0000
128 PAIN OF SKIN 1 0.0000
129 FREQUENT BOWEL MOVEMENTS 1 0.0000
130 OEDEMA 2 0.0000
131 SKIN LESION 1 0.0000
132 ARTHROPATHY 2 0.0000
133 FEELING COLD 1 0.0000
134 WOUND 1 0.0000
135 INTENTIONAL DOSE OMISSION 1 0.0000
136 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
137 RED BLOOD CELL COUNT DECREASED 1 0.0000
138 ANGINA PECTORIS 1 0.0000
139 LETHARGY 2 0.0000
140 DYSSTASIA 1 0.0000
141 SURGERY 2 0.0000
142 BLOOD POTASSIUM DECREASED 1 0.0000
143 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
144 SWELLING 3 0.0000
145 PARAESTHESIA 5 0.0000
146 NEUROPATHY PERIPHERAL 3 0.0000
147 GAIT DISTURBANCE 6 0.0000
148 MOVEMENT DISORDER 1 0.0000
149 CHOLELITHIASIS 1 0.0000
150 IMPAIRED HEALING 1 0.0000
151 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
152 SKIN DISORDER 1 0.0000
153 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
154 HEPATIC ENZYME INCREASED 2 0.0000
155 ABDOMINAL PAIN UPPER 6 0.0000
156 NEOPLASM PROGRESSION 1 0.0000
157 LYMPHADENOPATHY 1 0.0000
158 CEREBRAL HAEMORRHAGE 1 0.0000
159 PAIN IN EXTREMITY 8 0.0000
160 NASOPHARYNGITIS 5 0.0000
161 HYPOAESTHESIA 4 0.0000
162 FATIGUE 20 0.0000
163 BLINDNESS 1 0.0000
164 NEUTROPHIL COUNT DECREASED 1 0.0000
165 OSTEOARTHRITIS 1 0.0000
166 RECTAL HAEMORRHAGE 1 0.0000
167 THROAT IRRITATION 1 0.0000
168 ADVERSE DRUG REACTION 2 0.0000
169 MUSCLE SPASMS 4 0.0000
170 SKIN DISCOLOURATION 1 0.0000
171 WEIGHT DECREASED 6 0.0000
172 COGNITIVE DISORDER 1 0.0000
173 ASTHENIA 8 0.0000
174 FALL 7 0.0000
175 PRODUCTIVE COUGH 1 0.0000
176 RASH ERYTHEMATOUS 1 0.0000
177 MULTIPLE SCLEROSIS 1 0.0000
178 INFECTION 3 0.0000
179 ALOPECIA 4 0.0000
180 HYPOTENSION 4 0.0000
181 ILLNESS 2 0.0000
182 ABDOMINAL DISTENSION 2 0.0000
183 MUSCULOSKELETAL PAIN 1 0.0000
184 PANCREATITIS 1 0.0000
185 BRADYCARDIA 1 0.0000
186 PLATELET COUNT DECREASED 2 0.0000
187 DISTURBANCE IN ATTENTION 1 0.0000
188 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
189 NECK PAIN 1 0.0000
190 WEIGHT INCREASED 4 0.0000
191 ASTHMA 2 0.0000
192 FLATULENCE 1 0.0000
193 HERPES ZOSTER 1 0.0000
194 PRODUCT SUBSTITUTION ISSUE 1 0.0000
195 SEIZURE 2 0.0000
196 BACK PAIN 4 0.0000
197 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
198 LOSS OF CONSCIOUSNESS 2 0.0000
199 DEVICE DIFFICULT TO USE 1 0.0000
200 INFUSION RELATED REACTION 1 0.0000
201 BLOOD PRESSURE DECREASED 1 0.0000
202 INJECTION SITE PRURITUS 1 0.0000
203 VOMITING 7 0.0000
204 NEUTROPENIA 2 0.0000
205 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
206 VISION BLURRED 2 0.0000
207 HEADACHE 9 0.0000
208 COUGH 4 0.0000
209 SLEEP DISORDER 1 0.0000
210 DIZZINESS 7 0.0000
211 DIARRHOEA 9 0.0000
212 MOBILITY DECREASED 1 0.0000
213 UNDERDOSE 1 0.0000
214 AGITATION 1 0.0000
215 HOT FLUSH 1 0.0000
216 DEPRESSION 3 0.0000
217 DIABETES MELLITUS 1 0.0000
218 BLOOD PRESSURE INCREASED 2 0.0000
219 INJECTION SITE SWELLING 1 0.0000
220 DRUG DOSE OMISSION BY DEVICE 1 0.0000
221 INJECTION SITE BRUISING 1 0.0000
222 INJECTION SITE HAEMORRHAGE 1 0.0000
223 FEELING ABNORMAL 3 0.0000
224 CARDIAC FAILURE 1 0.0000
225 DYSPNOEA 7 0.0000
226 TREMOR 2 0.0000
227 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
228 URTICARIA 2 0.0000
229 MYALGIA 2 0.0000
230 URINARY TRACT INFECTION 2 0.0000
231 PYREXIA 4 0.0000
232 INTENTIONAL PRODUCT MISUSE 1 0.0000
233 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
234 INSOMNIA 3 0.0000
235 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
236 SUICIDAL IDEATION 1 0.0000
237 OROPHARYNGEAL PAIN 1 0.0000
238 HYPERSENSITIVITY 2 0.0000
239 DYSPHAGIA 1 0.0000
240 MIGRAINE 1 0.0000
241 CONTUSION 1 0.0000
242 DYSPEPSIA 1 0.0000
243 NAUSEA 8 0.0000
244 HEART RATE INCREASED 1 0.0000
245 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
246 CONDITION AGGRAVATED 3 0.0000
247 CHEST DISCOMFORT 1 0.0000
248 PNEUMONIA 3 0.0000
249 CONSTIPATION 2 0.0000
250 MALAISE 4 0.0000
251 ABDOMINAL PAIN 2 0.0000
252 PALPITATIONS 1 0.0000
253 DISEASE PROGRESSION 1 0.0000
254 OEDEMA PERIPHERAL 1 0.0000
255 PAIN 5 0.0000
256 VISUAL IMPAIRMENT 1 0.0000
257 INJECTION SITE ERYTHEMA 1 0.0000
258 DEHYDRATION 1 0.0000
259 ARTHRALGIA 3 0.0000
260 ANXIETY 2 0.0000
261 RASH 3 0.0000
262 PRODUCT DOSE OMISSION ISSUE 2 0.0000
263 CONFUSIONAL STATE 1 0.0000
264 ABDOMINAL DISCOMFORT 1 0.0000
265 CEREBROVASCULAR ACCIDENT 1 0.0000
266 PRODUCT USE ISSUE 1 0.0000
267 PRURITUS 2 0.0000
268 SOMNOLENCE 1 0.0000
269 ERYTHEMA 1 0.0000
270 HYPERTENSION 1 0.0000
271 INCORRECT DOSE ADMINISTERED 1 0.0000
272 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
273 OFF LABEL USE 3 0.0000
274 INJECTION SITE PAIN 1 0.0000
275 DRUG INEFFECTIVE 4 0.0000
276 DEATH 2 0.0000